{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:29:21Z","timestamp":1793532561626,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS088219"],"award-info":[{"award-number":["R01NS088219"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS102627"],"award-info":[{"award-number":["R01NS102627"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS106227"],"award-info":[{"award-number":["R01NS106227"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-54861-3","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T05:03:01Z","timestamp":1738645381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7091-3073","authenticated-orcid":false,"given":"Yuchen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaemin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Dismuke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4421-8688","authenticated-orcid":false,"given":"Daniel S.","family":"Malawsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3800-590X","authenticated-orcid":false,"given":"Sho","family":"Oasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zara C.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2518-1779","authenticated-orcid":false,"given":"Carolin","family":"Offenh\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8170-0567","authenticated-orcid":false,"given":"Ulrich","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle C. J.","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7428-4139","authenticated-orcid":false,"given":"Stacey L.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9770-0198","authenticated-orcid":false,"given":"Juliet D.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1680-3954","authenticated-orcid":false,"given":"Lucy S. H.","family":"Ock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4691-4989","authenticated-orcid":false,"given":"Haran","family":"Sivakumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7820-0921","authenticated-orcid":false,"given":"Lachlan","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey P.","family":"Tikunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duhyeong","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coral Del Mar","family":"Alicea Pauneto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mellissa","family":"Maybury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Hassall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Wainwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3772-6000","authenticated-orcid":false,"given":"Santosh","family":"Kesari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3588-8834","authenticated-orcid":false,"given":"Gregory","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Piper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8874-4543","authenticated-orcid":false,"given":"Terrance G.","family":"Johns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3462-9013","authenticated-orcid":false,"given":"Marina","family":"Sokolsky-Papkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2880-9576","authenticated-orcid":false,"given":"Lars","family":"Terenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0873-5653","authenticated-orcid":false,"given":"Vladana","family":"Vukojevic\u0301","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon F.","family":"McSwain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7034-6400","authenticated-orcid":false,"given":"Timothy R.","family":"Gershon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan W.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"54861_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom, Q. T. et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015. Neuro Oncol. 20, iv1\u2013iv86 (2018).","journal-title":"Neuro Oncol."},{"key":"54861_CR2","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/now207","volume":"18","author":"QT Ostrom","year":"2016","unstructured":"Ostrom, Q. T. et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013. Neuro Oncol. 18, v1\u2013v75 (2016).","journal-title":"Neuro Oncol."},{"key":"54861_CR3","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1200\/JCO.2009.27.4324","volume":"29","author":"PA Northcott","year":"2011","unstructured":"Northcott, P. A. et al. Medulloblastoma comprises four distinct molecular variants. J. Clin. Oncol. 29, 1408\u20131414 (2011).","journal-title":"J. Clin. Oncol."},{"key":"54861_CR4","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S1470-2045(06)70867-1","volume":"7","author":"A Gajjar","year":"2006","unstructured":"Gajjar, A. et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol. 7, 813\u2013820 (2006).","journal-title":"Lancet Oncol."},{"key":"54861_CR5","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1200\/JCO.2010.30.2299","volume":"28","author":"S Rutkowski","year":"2010","unstructured":"Rutkowski, S. et al. Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. J. Clin. Oncol. 28, 4961\u20134968 (2010).","journal-title":"J. Clin. Oncol."},{"key":"54861_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1037\/0894-4105.22.2.159","volume":"22","author":"DJ Mabbott","year":"2008","unstructured":"Mabbott, D. J. et al. Core neurocognitive functions in children treated for posterior fossa tumors. Neuropsychology 22, 159\u2013168 (2008).","journal-title":"Neuropsychology"},{"key":"54861_CR7","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1200\/JCO.2005.01.158","volume":"23","author":"DJ Mabbott","year":"2005","unstructured":"Mabbott, D. J. et al. Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J. Clin. Oncol. 23, 2256\u20132263 (2005).","journal-title":"J. Clin. Oncol."},{"key":"54861_CR8","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1200\/JCO.2004.05.186","volume":"22","author":"BJ Spiegler","year":"2004","unstructured":"Spiegler, B. J. et al. Change in neurocognitive functioning after treatment with cranial radiation in childhood. J. Clin. Oncol. 22, 706\u2013713 (2004).","journal-title":"J. Clin. Oncol."},{"key":"54861_CR9","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1200\/JCO.2003.01.202","volume":"21","author":"RJ Packer","year":"2003","unstructured":"Packer, R. J. et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J. Clin. Oncol. 21, 3255\u20133261 (2003).","journal-title":"J. Clin. Oncol."},{"key":"54861_CR10","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1093\/jnci\/djj411","volume":"98","author":"JP Neglia","year":"2006","unstructured":"Neglia, J. P. et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J. Natl Cancer Inst. 98, 1528\u20131537 (2006).","journal-title":"J. Natl Cancer Inst."},{"key":"54861_CR11","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nrn3386","volume":"13","author":"DH Meijer","year":"2012","unstructured":"Meijer, D. H. et al. Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2. Nat. Rev. Neurosci. 13, 819\u2013831 (2012).","journal-title":"Nat. Rev. Neurosci."},{"key":"54861_CR12","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S0960-9822(02)00926-0","volume":"12","author":"H Takebayashi","year":"2002","unstructured":"Takebayashi, H. et al. The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages. Curr. Biol. 12, 1157\u20131163 (2002).","journal-title":"Curr. Biol."},{"key":"54861_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0092-8674(02)00677-3","volume":"109","author":"Q Zhou","year":"2002","unstructured":"Zhou, Q. & Anderson, D. J. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 109, 61\u201373 (2002).","journal-title":"Cell"},{"key":"54861_CR14","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1016\/j.celrep.2017.03.003","volume":"18","author":"J Zhou","year":"2017","unstructured":"Zhou, J. et al. A sequentially priming phosphorylation cascade activates the gliomagenic transcription factor Olig2. Cell Rep. 18, 3167\u20133177 (2017).","journal-title":"Cell Rep."},{"key":"54861_CR15","doi-asserted-by":"publisher","first-page":"8507","DOI":"10.1523\/JNEUROSCI.0309-14.2014","volume":"34","author":"DH Meijer","year":"2014","unstructured":"Meijer, D. H. et al. An amino terminal phosphorylation motif regulates intranuclear compartmentalization of Olig2 in neural progenitor cells. J. Neurosci. 34, 8507\u20138518 (2014).","journal-title":"J. Neurosci."},{"key":"54861_CR16","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1080\/15384101.2017.1361062","volume":"16","author":"J Kosty","year":"2017","unstructured":"Kosty, J. et al. Harnessing OLIG2 function in tumorigenicity and plasticity to target malignant gliomas. Cell Cycle 16, 1654\u20131660 (2017).","journal-title":"Cell Cycle"},{"key":"54861_CR17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ccell.2019.07.009","volume":"36","author":"L Zhang","year":"2019","unstructured":"Zhang, L. et al. Single-cell transcriptomics in medulloblastoma reveals tumor-initiating progenitors and oncogenic cascades during tumorigenesis and relapse. Cancer Cell 36, 302\u2013318 e7 (2019).","journal-title":"Cancer Cell"},{"key":"54861_CR18","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s42003-021-02099-w","volume":"4","author":"DS Malawsky","year":"2021","unstructured":"Malawsky, D. S. et al. Cryptic developmental events determine medulloblastoma radiosensitivity and cellular heterogeneity without altering transcriptomic profile. Commun. Biol. 4, 616 (2021).","journal-title":"Commun. Biol."},{"key":"54861_CR19","doi-asserted-by":"crossref","unstructured":"Xu, Z. et al. OLIG2 is a determinant for the relapse of MYC-amplified medulloblastoma. Clin. Cancer Res. 28, 4278\u20134291 (2022)","DOI":"10.1158\/1078-0432.CCR-22-0527"},{"key":"54861_CR20","doi-asserted-by":"crossref","unstructured":"Torres-Machorro, A. L. Homodimeric and heterodimeric interactions among vertebrate basic helix-loop-helix transcription factors. Int. J. Mol. Sci. 22, 12855 (2021)","DOI":"10.3390\/ijms222312855"},{"key":"54861_CR21","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1021\/acschembio.6b00465","volume":"11","author":"AL Edwards","year":"2016","unstructured":"Edwards, A. L. et al. Challenges in targeting a basic helix-loop-helix transcription factor with hydrocarbon-stapled peptides. ACS Chem. Biol. 11, 3146\u20133153 (2016).","journal-title":"ACS Chem. Biol."},{"key":"54861_CR22","doi-asserted-by":"publisher","first-page":"22370","DOI":"10.18632\/oncotarget.5633","volume":"8","author":"IF Tsigelny","year":"2017","unstructured":"Tsigelny, I. F. et al. Multiple spatially related pharmacophores define small molecule inhibitors of OLIG2 in glioblastoma. Oncotarget 8, 22370\u201322384 (2017).","journal-title":"Oncotarget"},{"key":"54861_CR23","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1073\/pnas.1915531117","volume":"117","author":"S Oasa","year":"2020","unstructured":"Oasa, S. et al. A strategy for designing allosteric modulators of transcription factor dimerization. Proc. Natl Acad. Sci. USA 117, 2683\u20132686 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"54861_CR24","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccell.2017.05.005","volume":"31","author":"FMG Cavalli","year":"2017","unstructured":"Cavalli, F. M. G. et al. Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell 31, 737\u2013754.e6 (2017).","journal-title":"Cancer Cell"},{"key":"54861_CR25","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/s41591-018-0207-3","volume":"24","author":"S Brabetz","year":"2018","unstructured":"Brabetz, S. et al. A biobank of patient-derived pediatric brain tumor models. Nat. Med. 24, 1752\u20131761 (2018).","journal-title":"Nat. Med."},{"key":"54861_CR26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2217\/rme.14.26","volume":"9","author":"J Allard","year":"2014","unstructured":"Allard, J. et al. Immunohistochemical toolkit for tracking and quantifying xenotransplanted human stem cells. Regen. Med. 9, 437\u2013452 (2014).","journal-title":"Regen. Med."},{"key":"54861_CR27","doi-asserted-by":"publisher","first-page":"e0186091","DOI":"10.1371\/journal.pone.0186091","volume":"12","author":"AJ Darr","year":"2017","unstructured":"Darr, A. J. et al. Identification of genome-wide targets of Olig2 in the adult mouse spinal cord using ChIP-Seq. PLoS One 12, e0186091 (2017).","journal-title":"PLoS One"},{"key":"54861_CR28","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ccell.2016.03.027","volume":"29","author":"F Lu","year":"2016","unstructured":"Lu, F. et al. Olig2-dependent reciprocal shift in PDGF and EGF receptor signaling regulates tumor phenotype and mitotic growth in malignant glioma. Cancer Cell 29, 669\u2013683 (2016).","journal-title":"Cancer Cell"},{"key":"54861_CR29","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.stem.2019.04.014","volume":"24","author":"R Xu","year":"2019","unstructured":"Xu, R. et al. OLIG2 drives abnormal neurodevelopmental phenotypes in human ipsc-based organoid and chimeric mouse models of down syndrome. Cell Stem Cell 24, 908\u2013926.e8 (2019).","journal-title":"Cell Stem Cell"},{"key":"54861_CR30","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"Y Cheng","year":"1973","unstructured":"Cheng, Y. & Prusoff, W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharm. 22, 3099\u20133108 (1973).","journal-title":"Biochem Pharm."},{"key":"54861_CR31","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nrm2276","volume":"8","author":"M Sullivan","year":"2007","unstructured":"Sullivan, M. & Morgan, D. O. Finishing mitosis, one step at a time. Nat. Rev. Mol. Cell Biol. 8, 894\u2013903 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"54861_CR32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","volume":"180","author":"F Jacob","year":"2020","unstructured":"Jacob, F. et al. A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity. Cell 180, 188\u2013204.e22 (2020).","journal-title":"Cell"},{"key":"54861_CR33","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1038\/s41596-020-0402-9","volume":"15","author":"F Jacob","year":"2020","unstructured":"Jacob, F., Ming, G. L. & Song, H. Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR T cell testing. Nat. Protoc. 15, 4000\u20134033 (2020).","journal-title":"Nat. Protoc."},{"key":"54861_CR34","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1158\/0008-5472.CAN-13-0238","volume":"73","author":"J Ahlfeld","year":"2013","unstructured":"Ahlfeld, J. et al. Sox2 requirement in sonic hedgehog-associated medulloblastoma. Cancer Res. 73, 3796\u20133807 (2013).","journal-title":"Cancer Res."},{"key":"54861_CR35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00401-011-0800-8","volume":"121","author":"DW Ellison","year":"2011","unstructured":"Ellison, D. W. et al. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH\/WNT molecular subgroups. Acta Neuropathol. 121, 381\u2013396 (2011).","journal-title":"Acta Neuropathol."},{"key":"54861_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13657-6","volume":"10","author":"J Ocasio","year":"2019","unstructured":"Ocasio, J. et al. scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy. Nat. Commun. 10, 5829 (2019).","journal-title":"Nat. Commun."},{"key":"54861_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ccr.2014.05.005","volume":"26","author":"RJ Vanner","year":"2014","unstructured":"Vanner, R. J. et al. Quiescent sox2(+) cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma. Cancer Cell 26, 33\u201347 (2014).","journal-title":"Cancer Cell"},{"key":"54861_CR38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccr.2008.07.005","volume":"14","author":"U Sch\u00fcller","year":"2008","unstructured":"Sch\u00fcller, U. et al. Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form shh-induced medulloblastoma. Cancer Cell 14, 123\u2013134 (2008).","journal-title":"Cancer Cell"},{"key":"54861_CR39","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ccell.2016.03.002","volume":"29","author":"TN Phoenix","year":"2016","unstructured":"Phoenix, T. N. et al. Medulloblastoma genotype dictates blood brain barrier phenotype. Cancer Cell 29, 508\u2013522 (2016).","journal-title":"Cancer Cell"},{"key":"54861_CR40","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/neuonc\/noab135","volume":"24","author":"KA Riemondy","year":"2022","unstructured":"Riemondy, K. A. et al. Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma. Neuro Oncol. 24, 273\u2013286 (2022).","journal-title":"Neuro Oncol."},{"key":"54861_CR41","doi-asserted-by":"publisher","first-page":"e8746","DOI":"10.15252\/msb.20188746","volume":"15","author":"MD Luecken","year":"2019","unstructured":"Luecken, M. D. & Theis, F. J. Current best practices in single-cell RNA-seq analysis: a tutorial. Mol. Syst. Biol. 15, e8746 (2019).","journal-title":"Mol. Syst. Biol."},{"key":"54861_CR42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-0716-2752-5_11","volume":"2583","author":"D Malawsky","year":"2023","unstructured":"Malawsky, D. & Gershon, T. R. scRNA-seq for microcephaly research [IV]: dirichlet regression for single-cell population differences. Methods Mol. Biol. 2583, 123\u2013125 (2023).","journal-title":"Methods Mol. Biol."},{"key":"54861_CR43","doi-asserted-by":"publisher","first-page":"W212","DOI":"10.1093\/nar\/gkz446","volume":"47","author":"AB Keenan","year":"2019","unstructured":"Keenan, A. B. et al. ChEA3: transcription factor enrichment analysis by orthogonal omics integration. Nucleic Acids Res. 47, W212\u2013W224 (2019).","journal-title":"Nucleic Acids Res."},{"key":"54861_CR44","doi-asserted-by":"publisher","first-page":"26126","DOI":"10.1074\/jbc.M314305200","volume":"279","author":"Y Zhang","year":"2004","unstructured":"Zhang, Y. and A.W. Hamburger, Heregulin regulates the ability of the ErbB3-binding protein Ebp1 to bind E2F promoter elements and repress E2F-mediated transcription. J. Biol. Chem. 279, 26126\u201326133 (2004).","journal-title":"J. Biol. Chem."},{"key":"54861_CR45","doi-asserted-by":"publisher","first-page":"e13941","DOI":"10.1371\/journal.pone.0013941","volume":"5","author":"D Judah","year":"2010","unstructured":"Judah, D., Chang, W. Y. & Dagnino, L. EBP1 is a novel E2F target gene regulated by transforming growth factor-beta. PLoS One 5, e13941 (2010).","journal-title":"PLoS One"},{"key":"54861_CR46","doi-asserted-by":"publisher","first-page":"5802","DOI":"10.1158\/1078-0432.CCR-16-2943","volume":"23","author":"ML Cook Sangar","year":"2017","unstructured":"Cook Sangar, M. L. et al. Inhibition of CDK4\/6 by palbociclib significantly extends survival in medulloblastoma patient-derived xenograft mouse models. Clin. Cancer Res. 23, 5802\u20135813 (2017).","journal-title":"Clin. Cancer Res."},{"key":"54861_CR47","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1172\/JCI92710","volume":"128","author":"DR Raleigh","year":"2018","unstructured":"Raleigh, D. R. et al. Hedgehog signaling drives medulloblastoma growth via CDK6. J. Clin. Invest. 128, 120\u2013124 (2018).","journal-title":"J. Clin. Invest."},{"key":"54861_CR48","doi-asserted-by":"publisher","first-page":"eabl5838","DOI":"10.1126\/sciadv.abl5838","volume":"8","author":"C Lim","year":"2022","unstructured":"Lim, C. et al. Enhancing CDK4\/6 inhibitor therapy for medulloblastoma using nanoparticle delivery and scRNA-seq-guided combination with sapanisertib. Sci. Adv. 8, eabl5838 (2022).","journal-title":"Sci. Adv."},{"key":"54861_CR49","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/jnen\/63.5.499","volume":"63","author":"KL Ligon","year":"2004","unstructured":"Ligon, K. L. et al. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J. Neuropathol. Exp. Neurol. 63, 499\u2013509 (2004).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"54861_CR50","doi-asserted-by":"publisher","unstructured":"Desai, K. et al. OLIG2 mediates a rare targetable stem cell fate transition in sonic hedgehog medulloblastoma. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-024-54858-y (2025).","DOI":"10.1038\/s41467-024-54858-y"},{"key":"54861_CR51","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1158\/1078-0432.CCR-10-1178","volume":"17","author":"F Galimberti","year":"2011","unstructured":"Galimberti, F. et al. Anaphase catastrophe is a target for cancer therapy. Clin. Cancer Res. 17, 1218\u20131222 (2011).","journal-title":"Clin. Cancer Res."},{"key":"54861_CR52","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/stem.480","volume":"28","author":"CL Maire","year":"2010","unstructured":"Maire, C. L. et al. Gain-of-function of Olig transcription factors enhances oligodendrogenesis and myelination. Stem Cells 28, 1611\u20131622 (2010).","journal-title":"Stem Cells"},{"key":"54861_CR53","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12264-019-00449-7","volume":"36","author":"X Chen","year":"2020","unstructured":"Chen, X. et al. Myelin deficits caused by Olig2 deficiency lead to cognitive dysfunction and increase vulnerability to social withdrawal in adult mice. Neurosci. Bull. 36, 419\u2013426 (2020).","journal-title":"Neurosci. Bull."},{"key":"54861_CR54","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41568-019-0223-8","volume":"20","author":"V Hovestadt","year":"2020","unstructured":"Hovestadt, V. et al. Medulloblastomics revisited: biological and clinical insights from thousands of patients. Nat. Rev. Cancer 20, 42\u201356 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"54861_CR55","doi-asserted-by":"publisher","first-page":"16480","DOI":"10.1073\/pnas.1117943109","volume":"109","author":"DJ Miller","year":"2012","unstructured":"Miller, D. J. et al. Prolonged myelination in human neocortical evolution. Proc. Natl. Acad. Sci. USA 109, 16480\u201316485 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"54861_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/glia.20273","volume":"54","author":"KL Ligon","year":"2006","unstructured":"Ligon, K. L. et al. Olig gene function in CNS development and disease. Glia 54, 1\u201310 (2006).","journal-title":"Glia"},{"key":"54861_CR57","doi-asserted-by":"publisher","first-page":"i112","DOI":"10.1093\/cercor\/bhj167","volume":"16","author":"SM Pollard","year":"2006","unstructured":"Pollard, S. M. et al. Adherent neural stem (NS) cells from fetal and adult forebrain. Cereb. Cortex 16, i112\u2013i120 (2006).","journal-title":"Cereb. Cortex"},{"key":"54861_CR58","doi-asserted-by":"crossref","unstructured":"D\u2019Souza, R. C. J. et al. Q-cell glioblastoma resource: proteomics analysis reveals unique cell-states are maintained in 3D culture. Cells 9, 267 (2020)","DOI":"10.3390\/cells9020267"},{"key":"54861_CR59","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1128\/MCB.02005-06","volume":"27","author":"PS Linsley","year":"2007","unstructured":"Linsley, P. S. et al. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol. Cell Biol. 27, 2240\u20132252 (2007).","journal-title":"Mol. Cell Biol."},{"key":"54861_CR60","doi-asserted-by":"publisher","first-page":"102345","DOI":"10.1016\/j.nano.2020.102345","volume":"32","author":"D Hwang","year":"2021","unstructured":"Hwang, D. et al. Poly(2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicity. Nanomedicine 32, 102345 (2021).","journal-title":"Nanomedicine"},{"key":"54861_CR61","doi-asserted-by":"crossref","unstructured":"Tran, V. et al. High sensitivity single cell RNA sequencing with split pool barcoding. BioRxiv https:\/\/www.biorxiv.org\/content\/10.1101\/2022.08.27.505512v1 (2022).","DOI":"10.1101\/2022.08.27.505512"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54861-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54861-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54861-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T05:03:06Z","timestamp":1738645386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54861-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["54861"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-54861-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2949436\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"17 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.S. is the Chief Executive Officer, Chairman of the Board and has equity ownership at Curtana Pharmaceuticals. S.K. is a member of the Board and has equity ownership at Curtana Pharmaceuticals. The other co-authors have no competing interests to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1091"}}